2 not yet recruiting, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Not yet recruiting 2, Recruiting 1 |
Follow Subodh Verma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Baxdrostat and Ventricular Remodeling Baxdrostat, Placebo - Cardiac Remodeling | Phase 3 | Not yet recruiting | Subodh Verma | 286 | 2026-06-30 | 2026-06-17 |
| SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure Empagliflozin 10 mg, Placebo - Congenital Heart Disease | Phase 3 | Recruiting | Subodh Verma | 410 | 2026-05-29 | 2026-09-02 |
| Finerenone and Cardiac Remodeling Finerenone, Placebo - Heart Failure | Phase 3 | Not yet recruiting | Subodh Verma | 156 | 2025-12-01 | 2025-12-08 |
Ventricular Remodeling (2) · Heart Defects, Congenital (1) · Heart Failure (1)
empagliflozin (1) · finerenone (1)
Canada (3)